Your browser doesn't support javascript.
loading
First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial.
Paz-Ares, Luis; Ciuleanu, Tudor-Eliade; Cobo, Manuel; Schenker, Michael; Zurawski, Bogdan; Menezes, Juliana; Richardet, Eduardo; Bennouna, Jaafar; Felip, Enriqueta; Juan-Vidal, Oscar; Alexandru, Aurelia; Sakai, Hiroshi; Lingua, Alejo; Salman, Pamela; Souquet, Pierre-Jean; De Marchi, Pedro; Martin, Claudio; Pérol, Maurice; Scherpereel, Arnaud; Lu, Shun; John, Thomas; Carbone, David P; Meadows-Shropshire, Stephanie; Agrawal, Shruti; Oukessou, Abderrahim; Yan, Jinchun; Reck, Martin.
Afiliação
  • Paz-Ares L; Hospital Universitario 12 de Octubre, CNIO-H12o Lung Cancer Unit, Universidad Complutense & CiberOnc, Madrid, Spain. Electronic address: lpazaresr@seom.org.
  • Ciuleanu TE; Institutul Oncologic Prof Dr Ion Chiricuta and UMF Iuliu Hatieganu, Cluj-Napoca, Romania.
  • Cobo M; Unidad de Gestión Clínica Intercentros de Oncología Médica, Hospitales Universitarios Regional y Virgen de la Victoria, IBIMA, Málaga, Spain.
  • Schenker M; SF Nectarie Oncology Center, Craiova, Romania.
  • Zurawski B; Ambulatorium Chemioterapii, Bydgoszcz, Poland.
  • Menezes J; Hospital Nossa Senhora Da Conceição, Porto Alegre, Brazil.
  • Richardet E; Instituto Oncológico De Córdoba, Córdoba, Argentina.
  • Bennouna J; Thoracic Oncology Unit, University Hospital of Nantes and INSERM, CRCINA, Nantes, France.
  • Felip E; Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain.
  • Juan-Vidal O; Hospital Universitario La Fe, Valencia, Spain.
  • Alexandru A; Institute of Oncology Prof Dr Alexandru Trestioreanu Bucha, Bucharest, Romania.
  • Sakai H; Saitama Cancer Center, Saitama, Japan.
  • Lingua A; Instituto Medico Rio Cuarto SA, Córdoba, Argentina.
  • Salman P; Fundacion Arturo Lopez Perez, Santiago, Metropolitana, Chile.
  • Souquet PJ; Hôpital Lyon Sud, Lyon, Pierre Bénite, France.
  • De Marchi P; Barretos Cancer Hospital, Barretos, Brazil.
  • Martin C; Instituto Alexander Fleming, Buenos Aires, Argentina.
  • Pérol M; Léon Bérard Cancer Center, Lyon, France.
  • Scherpereel A; Pulmonary and Thoracic Oncology, University of Lille, CHU Lille, INSERM U1189, OncoThAI, Lille, France.
  • Lu S; Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai JiaoTong University, Shanghai, China.
  • John T; Austin Hospital, Heidelberg, VIC, Australia.
  • Carbone DP; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
  • Meadows-Shropshire S; Bristol Myers Squibb, Princeton, NJ, USA.
  • Agrawal S; Bristol Myers Squibb, Princeton, NJ, USA.
  • Oukessou A; Bristol Myers Squibb, Princeton, NJ, USA.
  • Yan J; Bristol Myers Squibb, Princeton, NJ, USA.
  • Reck M; Department of Thoracic Oncology, Airway Research Center North, German Center for Lung Research, LungClinic, Grosshansdorf, Germany.
Lancet Oncol ; 22(2): 198-211, 2021 02.
Article em En | MEDLINE | ID: mdl-33476593
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Pulmonar de Células não Pequenas / Ipilimumab / Nivolumabe Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Pulmonar de Células não Pequenas / Ipilimumab / Nivolumabe Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article